A detailed history of Engineers Gate Manager LP transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 12,600 shares of ALXO stock, worth $22,932. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,600
Holding current value
$22,932
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.84 - $17.56 $73,584 - $221,255
12,600 New
12,600 $75,000
Q1 2022

May 16, 2022

SELL
$13.65 - $22.06 $146,055 - $236,042
-10,700 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$21.49 - $74.4 $229,942 - $796,080
10,700 New
10,700 $230,000

Others Institutions Holding ALXO

About ALX ONCOLOGY HOLDINGS INC


  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $74.2M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.